PharmaTher Holdings Ltd. (PHRM.CN) Stock Overview
Explore PharmaTher Holdings Ltd.’s financial performance, market position, analyst ratings, and future outlook.
PharmaTher Holdings Ltd. (PHRM.CN)
Key Financials
Key Financials
Market Cap
5M
P/E Ratio
-4.96
EPS (TTM)
$-0.02
ROE
-1.55%
PHRM.CN Stock Analysis & Investment Overview (CNQ)
Our AI-powered analysis of PharmaTher Holdings Ltd. (CNQ: PHRM.CN) gives investors deep insight into how the stock performs on the CNQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, PharmaTher Holdings Ltd.'s CNQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PHRM.CN on the CNQ shows an RSI of 55.21, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the CNQ listing.
Key metrics behind PharmaTher Holdings Ltd.'s CNQ-traded stock include a P/E ratio of -4.96 and a market capitalization of 5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PHRM.CN on the CNQ.